Printer Friendly

New path for antibiotic approvals?

Congress will consider a new drug approval pathway in an effort to encourage development of critically needed, lifesaving antibiotics as part of a strategy to address the public health crisis of antibiotic resistance, the Infectious Diseases Society of America said. The society proposed the new pathway to help streamline approval of new antibiotics for serious infections where few or no treatment options currently exist. The proposed mechanism would enable pharmaceutical companies to study "Special Population Limited Medical Use" drugs in far fewer patients than currently is required, more rapidly, and at significantly less cost. The drugs would be reserved for use in specific patient populations that lack other treatment options, and would include warnings designed to encourage prudent use and slow the development of resistance, according to the society.
COPYRIGHT 2012 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:POLICY & PRACTICE
Author:Anderson, Jane
Publication:Internal Medicine News
Date:Apr 1, 2012
Previous Article:Malpractice suits' impact small.
Next Article:Consumers eager to try exchanges.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters